FDA’s Opdivo Lung Cancer Approval

By João L. Carapinha

October 11, 2024

The FDA has approved a new treatment regimen using Opdivo (nivolumab) for resectable non-small cell lung cancer (NSCLC), marking a significant advancemen...
Mental Healthcare for Youth: Addressing Substance Use and Chronic Conditions
Depression and Life Satisfaction in Pregnant Women
The VA’s Journey with Early Adoption of AI in Healthcare
Enhancing Global Health through Regulatory Collaboration
Enhancing Child Mental Health Services with Digital Interventions
Strategic Phased Launch of Tirzepatide for Obesity Treatment in England
Mental Health Trends Among US Youths: Rising Prevalence of Depression and Anx...
The Trump Drug Policy Change: A Reverse Course
WHO Introduces HPV Single-Dose Vaccine to Boost Cervical Cancer Elimination E...
Created and Validated by FDA: AI Drug Safety Surveillance Tool
The Role of School-Based Health Centres in Advancing Health Equity
Enhancing Care in Abu Dhabi: The New ABA Guidelines for Autism